Woodstock Corp Eye Point Pharmaceuticals, Inc. Transaction History
Woodstock Corp
- $1.03 Billion
- Q4 2024
A detailed history of Woodstock Corp transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodstock Corp holds 71,480 shares of EYPT stock, worth $473,197. This represents 0.05% of its overall portfolio holdings.
Number of Shares
71,480
Previous 71,480
-0.0%
Holding current value
$473,197
Previous $571,000
6.83%
% of portfolio
0.05%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
154Shares Held
58.2MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$55.1 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$34.3 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$26.6 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$25.1 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$24.9 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $226M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...